Current and emerging research needs in studying the NYC HIV-drug Use epidemic

Substance Use and Misuse

Volumn 46, Issue 2-3, 2011, Pages 316-319

  Deren, Sherry ^a   Hagan, Holly ^a   Friedman, Samuel ^b   Des Jarlais, Don C ^c   Perlman, David ^c   Gwadz, Marya ^a   Cleland, Charles ^a   Osborne, Andrew ^b   Lunievicz, Joseph ^b  

^a NEW YORK UNIVERSITY   (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

drug use; HIV; NYC

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); EPIDEMIC; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; RESEARCH;

CLINICAL TRIALS AS TOPIC; EPIDEMICS; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; RESEARCH;

EID: 79951558941     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2011.523324     Document Type: Article

References (31)

1. Amesty, S., Rivera, A., & Fuller, C.(2011).Overview of HIV among injection drug users in New York City: Critical next steps to eliminate racial/ethnic disparities.Substance Use & Misuse, 46(2-3), 285-294.
2. Brenner, B.G., Roger, M., Routy, J.P., Moisi, D., Ntemgwa, M., Matte, C., et al.(2007).High rates of forward transmission events after acut (Pubitemid 46452099)
3. Centers for Disease Control and Prevention.(2009).HIV/AIDS Surveillance Report, 2007.Retrieved July 2, 2010, from http://www.cdc.gov/hiv/topics/ surveillance/resources/reports/2007report/table 14.htm
4. Cunningham, C., Sohler, N., Cooperman, N., Berg, K., Litwin, A., & Arnsten, J.(2011).Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users.Substance Use & Misuse, 46(2-3), 218-232.
5. Deren, S., Shedlin, M., Kang, S.-Y., & Cortes, D.(2011).HIV risk and prevention among Hispanic immigrants in NY: The salience of diversity.Substance Use & Misuse, 46(2-3), 254-263.
6. Des Jarlais, D., Arasteh, K., & Friedman, S.(2011).HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years.Substance Use & Misuse, 46(2-3), 131-139.
7. El-Bassel, N.,Gilbert, L.,Witte, S.,Wu, E.,&Chang, M.(2011).Intimate partner violence and HIV among drug-involved women: Contexts linking these two epidemics-Challenges and implications for prevention and treatment.Substance Use & Misuse, 46(2-3), 295-306.
8. Freudenberg, N.(2011).HIV in the epicenter of the epicenter: HIV and drug use among criminal justice populations in New York City, 1980-2007.Substance Use & Misuse, 46(2-3), 159-170.
9. Friedman, S.R., Bolyard,M., Khan,M., Maslow, C., Sandoval, M., Mateu-Gelabert, P., et al.(2008).Group sex events and HIV/STI risk in an urban network.Journal of Acquired Immune Deficiency Syndromes, 49(4), 440-446.
10. Friedman, S.R., Bolyard, M., Mateu-Gelabert, P., Goltzman, P., Pawlowicz, M.P., Singh, D.Z., et al.(2007).Some data-driven reflections on priorities in AIDS network research.AIDS and Behavior, 11(5), 641-651. (Pubitemid 47327562)
11. Friedman, S.R., Kottiri, B.J., Neaigus, A., Curtis, R., Vermund, S.H., & Des Jarlais, D.C.(2000).Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation.American Journal of Epidemiology, 152(10), 913-922.
12. Friedman, S., Pouget, E., Chattejee, S., Cleland, C., Tempalski, B., Brady, J., et al.(in press).Do drug arrests deter injection drug use? American Journal of Public Health.
13. Friedman, S., Sandoval, M., Mateu-Gelabert, M., Meylakhs, P., & Des Jarlais D.C.(2011).Symbiotic goals and the prevention of blood-borne viruses among injection drug users.Substance Use & Misuse, 46(2-3), 307-315.
14. Furst, T., Curtis, R., & Balletto, R.(2011).The transformation of drug markets and its impact on HIV outreach to injection drug users in New York City, 1987-2008.Substance Use & Misuse, 46(2-3), 150-158.
15. Gwadz, M.V., Cylar, K., Leonard, N.R., Riedel, M., Herzog, N., Arredondo, G.N., et al.(2010).An exploratory behavioral intervention trial to improve rates of screening for AIDS clinical trials among racial/ethnic minority and female persons living with HIV/AIDS.AIDS and Behavior, 14(3), 639-648.
16. Gwadz, M., Leonard, N., Cleland, C., Colon, P., Banfield, A., Middleton, S., et al.(2010, July).Peer-driven intervention increases rates of screening for AIDS Clinical Trials among persons living with HIV/AIDS from racial/ethnic minority backgrounds.Paper presented at the XVIII International AIDS Conference, Vienna, Austria.
17. Hagan, H., Perlman, D., & Des Jarlais, D.(2011).Sexual risk and HIV infection among drug users in New York City: a pilot study.Substance Use & Misuse, 46(2-3), 201-207.
18. Hagan, H., Thiede, H., & Des Jarlais, D.C.(2005).HIV/hepatitis C virus co-infection in drug users: Risk behavior and prevention.AIDS, 19(Suppl.3), S199-S207. (Pubitemid 41682188)
19. Halkitis, P., Pollock, J., Pappas, M., Dayton, A., Moeller, R., Siconolfi, D., et al.(2011).Substance use in the MSM population of New York City during the era of HIV/AIDS.Substance Use & Misuse, 46(2-3), 264-273.
20. Heller, D., & Paone, D.(2011).Access to sterile syringes for injecting drug users in New York City: Politics and perception (1984-2010).Substance Use & Misuse, 46(2-3), 140-149.
21. Jenness, S., Hagan, H., Liu, K.-L.,Wendel, T.,&Murrill, C.(2011).Continuing HIV risk in New York City injection drug users: The association of syringe source and syringe sharing.Substance Use & Misuse, 46(2-3), 192-200.
22. Klein, R.(2011).Trends related to aging and co-occurring disorders in HIV infected drug users.Substance Use & Misuse, 46(2-3), 233-244.
23. Marks, G., Crepaz, N., Senterfitt, J.W., & Janssen, R.S.(2005).Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs.Journal of Acquired Immune Deficiency Syndromes, 39(4), 446-453. (Pubitemid 41003791)
24. Mateu-Gelabert, P., Sandoval, M., Meylakhs, P., Wendel, T., & Friedman, S.R.(2010).Strategies to avoid opiate withdrawal: Implications for HCV and HIV risks.Journal of Drug Policy, 21(3), 179-185.
25. Mehta, S.H., Kirk, G.D., Astemborski, J., Galai, N., & Celentano, D.D.(2010).Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008.Clinical Infectious Diseases, 50(12), 1664-1671.
26. Neaigus, A., Miller, M., Gyarmathy, A., & Friedman, S.(2011).HIV heterosexual risk from injecting drug users among HIV seronegative non-injecting heroin users.Substance Use & Misuse, 46(2-3), 208-217.
27. Ompad, D., Friedman, S., Hwahng, S., Nandi, V., Fuller, C., & Vlahov, D.(2011).HIV risk behaviors among young drug using women who have sex with women (WSWs) in New York City.Substance Use & Misuse, 46(2-3), 274-284.
28. Pfeiffer, M., Hanna, D., Begier, E., Sepkowitz, K., Zimmerman, R., & Sackoff, J.(2011).Excess mortality among injection drug users with AIDS, New York City 1999-2004.Substance Use & Misuse, 46(2-3), 245-253.
29. Strauss, S., & Mino, M.(2011).Addressing the HIV-related needs of substancemisusers in New York State: The benefits and barriers implementing a "one stop shopping" model.Substance Use & Misuse, 46(2-3), 171-180.
30. Strauss, S.M., Tiburcio, N.J., Munoz-Plaza, C., Gwadz, M., Lunievicz, J., Osborne, A., et al.(2009).HIV care providers' implementation of routine alcohol reduction support for their patients.AIDS Patient Care and STDs, 23(3), 211-218.
31. Vlahov, D., Ompad, D., Fuller, C.,&Nandi, V.(2011).Comparison of HIV risk by duration of injection drug use.Substance Use & Misuse, 46(2-3), 181-191.